Companies / Outlook Therapeutics
Outlook Therapeutics
United States
Outlook Therapeutics is focused on advancing innovative ophthalmic therapies for retinal diseases.
Outlook Therapeutics, based in United States, has 1 investor on file, among them Avoro Capital Advisors. Its site was last checked 20 Nov 2026: site answers.
SEC Form D filings
6 filingsFiled by Outlook Therapeutics, Inc. with the SEC. A Form D reports a private offering; it is not a priced round.
Investors
1 investor on file| Investor | Evidence | Type |
|---|---|---|
| Portfolio page | Investor |
More from Avoro Capital Advisors
60 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (100%), Media & Entertainment (2%), Consumer (2%).
See Avoro Capital Advisors' full profile · Who invests alongside it
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get Outlook Therapeutics and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Avoro Capital Advisors adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/outlooktherapeutics.com/investors
# also
GET /v1/companies/outlooktherapeutics.com
GET /v1/companies/outlooktherapeutics.com/news